The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Prostatitis: A Review
Abstract
Importance: Prostatitis is defined as infection, inflammation, or pain of the prostate gland and affects approximately 9.3% of men in their lifetime. Observations: Acute bacterial prostatitis consists of a urinary tract infection (UTI) that includes infection of the prostate, typically associated with fever or chills and caused by gram-negative bacteria, such as Escherichia coli, Klebsiella, or Pseudomonas , in 80% to 97% of cases. First-line therapy for acute prostatitis is broad-spectrum intravenous or oral antibiotics, such as intravenous piperacillin-tazobactam, ceftriaxone, or oral ciprofloxacin, which has a 92% to 97% success rate when prescribed for 2 to 4 weeks for people with febrile UTI and acute prostatitis. Chronic bacterial prostatitis is defined as a persistent bacterial infection of the prostate, typically presenting as recurrent UTIs from the same strain. Up to 74% of chronic bacterial prostatitis diagnoses are due to gram-negative organisms, such as E coli . First-line therapy for chronic bacterial prostatitis is a minimum 4-week course of levofloxacin or ciprofloxacin. Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) presents as pelvic pain or discomfort for at least 3 months and is associated with urinary symptoms, such as urinary frequency. CP/CPPS is diagnosed when evaluation, including history and physical examination, urine culture, and postvoid residual measurement, does not identify other causes for the symptoms, such as infection, cancer, urinary obstruction, or urinary retention. The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) measures symptom severity (scale of 0-43), with a 6-point change considered clinically meaningful. First-line oral therapy for CP/CPPS with urinary symptoms is α-blockers (eg, tamsulosin, alfuzosin; ΔNIH-CPSI score difference vs placebo = −10.8 to −4.8). Other oral therapies are associated with modest changes in NIH-CPSI score compared with placebo, including anti-inflammatory drugs (eg, ibuprofen; ΔNIH-CPSI score difference = −2.5 to −1.7), pregabalin (ΔNIH-CPSI score difference = −2.4), and pollen extract (ΔNIH-CPSI score difference = −2.49). Conclusions and Relevance: Prostatitis includes acute bacterial prostatitis, chronic bacterial prostatitis, and CP/CPPS, each of which is diagnosed and treated differently. First-line treatments are broad-spectrum antibiotics for acute bacterial prostatitis (such as piperacillin-tazobactam, ceftriaxone, or ciprofloxacin), at least 4 weeks of fluoroquinolones for chronic bacterial prostatitis, and α-blockers for CP/CPPS with urinary symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
NIH Consensus Definition and Classification of Prostatitis
Krieger, J. N., Nyberg, Jr., & Nickel, J. C. (1999) · JAMA · doi:10.1001/jama.282.3.236 · Cited by 1,473
LITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Bacteriologic localization patterns in bacterial prostatitis and urethritis.
Meares, E. M., & Stamey, T. A. (1968) · PubMed · Cited by 706
Whelton, A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00113-8 · Cited by 704
Shoskes, D. A., Zeitlin, S. I., Shahed, A., & Rajfer, J. (1999) · Urology · doi:10.1016/s0090-4295(99)00358-1 · Cited by 408
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome
Clemens, J. Q., Erickson, D. R., Varela, N. P., & Lai, H. H. (2022) · Journal of Urology · doi:10.1097/ju.0000000000002756 · Cited by 362
Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature
Khaliq, Y., & Zhanel, G. G. (2003) · Clinical Infectious Diseases · doi:10.1086/375078 · Cited by 357
European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines
Kranz, J., Bartoletti, R., Bruyère, F., Cai, T., Geerlings, S., Köves, B., Schubert, S., Pilatz, A., Veeratterapillay, R., Wagenlehner, F. M. E., et al. (2024) · European Urology · doi:10.1016/j.eururo.2024.03.035 · Cited by 340
Roberts, R. O., Lieber, M. M., Rhodes, T., Girman, C. J., Bostwick, D. G., & Jacobsen, S. J. (1998) · Urology · doi:10.1016/s0090-4295(98)00034-x · Cited by 294
Research works printed but not linked: 1
- Nickel, 2012, Male Lower Urinary Tract Symptoms (LUTS): An International Consultation on Male LUTS, 335
Cited by
Prostatitis-Related Male Infertility: From Inflammation and Dysbiosis to Sperm DNA Damage
Kaltsas, A., Pantazis, N., Tzikoulis, V., Roidos, C., Palapela, N., Tsiampali, C., Symeonidis, E. N., Zachariou, A., Sofikitis, N., & Dimitriadis, F. (2026) · Diagnostics · doi:10.3390/diagnostics16050722 · Cited by 7
Artificial intelligence in optimizing antimicrobial therapy for gastro-renal disorders
Stoia, O., Anderco, P., Badiu, T., Todor, S. B., & Ichim, C. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1792361 · Cited by 6
Advances in immunological research on male infertility
Liu, Z., Yang, X., Ji, Y., Wang, S., & Wang, J. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1752758 · Cited by 2
Li, Z., Yan, R., Lao, Y., Guan, X., Xiao, X., He, H., Li, R., Tao, Y., & Dong, Z. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112623 · Cited by 2
Huang, J., Liao, Z., Zhao, S., Lv, B., & Liang, K. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1714803 · Cited by 1
Metadata
- Authors
- Borgert, B. J., Wallen, E. M., & Pham, M. N.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Medical University of South Carolina (US)
- ORCID
- Pham, Minh N.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2025-09-16
- Volume
- 334
- Issue
- 11
- Pages
- 1003
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4413100355
- Cited by
- 50
- References
- 77
- Citations by year
- 2026: 44 · 2025: 6
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Keywords
- acute bacterial prostatitis, chronic bacterial prostatitis, chronic prostatitis/chronic pelvic pain syndrome, urinary tract infection, Escherichia coli, Gram-negative bacteria, antibiotic therapy, levofloxacin, ciprofloxacin, alpha-blockers, tamsulosin, alfuzosin, NIH Chronic Prostatitis Symptom Index
- MeSH terms
- Pregabalin, Acute Disease, Adrenergic alpha-Antagonists, Anti-Inflammatory Agents, Anti-Bacterial Agents, Bacterial Infections, Biological Products, Chronic Disease, Drug Therapy, Combination, Humans, Male, Prostatitis, Urinary Tract Infections, Polyphenols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prostatitis: A Review. https://app.cochat.ai/papers/10.1001/jama.2025.11499
- The paper
- Borgert, B. J., Wallen, E. M., & Pham, M. N. (2025). Prostatitis: A Review. JAMA. https://doi.org/10.1001/jama.2025.11499
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.